Sharps and needlestick injuries are common in dermatology practice, but they need not be inevitable.
Each year the CES exhibit showcases the latest in technology, including an impressive array of medical technology, aimed at both healthcare practitioners and consumers.
The use of a ceramide-infused ostomy skin barrier significantly decreased cost of care and increased satisfaction with patient-reported outcomes.
The US Centers for Disease Control and Prevention has released new data in its Antibiotic Resistance Investment Map, which shows states' progress in combating antibiotic resistance.
The FDA has granted Fast Track designation for CTP-543, a novel oral Janus kinase inhibitor for the treatment of moderate-to-severe alopecia areata, which currently has no approved treatments.
A case reports on a newborn with congenital toxoplasmosis who was safely and successfully treated with agents that caused Stevens-Johnson syndrome (SJS) in the mother.
Black women with central centrifugal cicatricial alopecia have increased likelihood of uterine leiomyomas and dermatologists are recommending screening when appropriate.
A cost-benefit analysis might be advantageous in defining the proper place of repository corticotropin injection in the treatment algorithm of myositis.
The shock wave device, which uses energy pulses to stimulate the wound and should be used with standard diabetic ulcer care, is the first intended to treat diabetic foot ulcers.
Based on data from patient consultations, researchers found that the percentage of European dermatologists recognizing signs of depression or anxiety was 44% for depression and 35.6% for anxiety.
Additional studies designed to develop a clinical score that is reflective of signs of disease activity are warranted.
Aclaris Therapeutics announced that the Food and Drug Administration has approved Eskata topical solution for the treatment of raised seborrheic keratoses.
The cause of dermographism, also known as dermographic urticaria, is unknown, but appears to be related to a mast cell abnormality and is probably autoimmune in nature.
Scientists continue to be the targets of legal action from pharmaceutical, medical device, and nutraceutical companies when published studies frame these companies' products in an unfavorable light.
In 2016 there was a deceleration in health spending growth, following faster growth in 2014 and 2015, in association with Affordable Care Act coverage expansions and strong retail prescription drug spending growth.
Researchers found that hair density was significantly improved at day 28 and at month 6 with platelet-rich plasma injection treatments, as well as a significant histological improvement.
The probability of achieving clinical remission in dermatomyositis was examined in a study to gauge the need for new pharmacotherapy addressing cutaneous outcomes.
The researchers found that the expedited programs included priority review (90 drugs), accelerated approval (26 drugs), fast-track (63 drugs), and breakthrough (29 drugs).
Exposure to ultraviolet phototherapy causes a degradation of folate levels, which may affect women of childbearing age, predisposing newborn babies to neural tube defects.
Dermatology Advisor Articles
- Specific Oral Bacteria May Reduce Risk for Squamous Cell Carcinoma
- Ostomy-Related Costs Reduced With Ceramide-Infused Skin Barrier
- Pediatric Psoriasis Associated With Increased Risk for Comorbidity Development
- Improved Neck, Décolletage Lines With Ultrasound, Diluted Calcium Hydroxylapatite
- New Nutrition Science Course Available for Physicians